{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:09Z","timestamp":1790679189803,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ymgme.2013.03.008","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T07:15:23Z","timestamp":1363850123000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fabry patients' experiences with the timing of diagnosis relevant for the discussion on newborn screening"],"prefix":"10.1016","volume":"109","author":[{"given":"Machtelt G.","family":"Bouwman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minke H.","family":"de Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor E.","family":"Linthorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits A.","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra C.B.","family":"van Zwieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.03.008_bb0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0010","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pediatrneurol.2008.11.010","article-title":"Newborn screening for Krabbe disease: the New York State model","volume":"40","author":"Duffner","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.2004-0583","article-title":"Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy","volume":"114","author":"Meikle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.02.026","article-title":"Newborn bloodspot screening for lysosomal storage disorders","author":"Zhou","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0030","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","article-title":"Fabry's disease: alpha-galactosidase deficiency","volume":"167","author":"Kint","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0045","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/adc.2009.171827","article-title":"\u2018Doctor Google\u2019 ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases","volume":"95","author":"Bouwman","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","article-title":"Clinical features of Fabry's disease in Australian patients","volume":"32","author":"Galanos","year":"2002","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0065","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0075","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","article-title":"Clinical benefit of enzyme replacement therapy in Fabry disease","volume":"69","author":"Breunig","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0080","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","article-title":"Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2mg\/kg","volume":"2","author":"Vedder","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0090","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0095","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cca.2010.03.009","article-title":"Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry","volume":"411","author":"Dajnoki","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0100","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1373\/clinchem.2010.152009","article-title":"A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler)","volume":"56","author":"Duffey","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0105","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1373\/clinchem.2004.037937","article-title":"Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease","volume":"50","author":"Fuller","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","article-title":"Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders","volume":"29","author":"Gelb","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0115","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/ac900504s","article-title":"New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography\/mass spectrometry","volume":"81","author":"la","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0120","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","article-title":"Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening","volume":"50","author":"Li","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0125","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","article-title":"Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry","volume":"54","author":"Zhang","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-60761-459-3_32","article-title":"Multiplex lysosomal enzyme activity assay on dried blood spots using tandem mass spectrometry","volume":"603","author":"Zhang","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0135","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A)","volume":"30","author":"Hwu","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0150","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0004.2007.00783.x","article-title":"Newborn screening for mucopolysaccharidoses: opinions of patients and their families","volume":"71","author":"Hayes","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0155","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jpeds.2005.08.011","article-title":"Delayed diagnosis of cystic fibrosis and the family perspective","volume":"147","author":"Kharrazi","year":"2005","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0160","doi-asserted-by":"crossref","first-page":"F91","DOI":"10.1136\/fn.86.2.F91","article-title":"Newborn screening for Duchenne muscular dystrophy: a psychosocial study","volume":"86","author":"Parsons","year":"2002","journal-title":"Arch. Dis. Child Fetal. Neonatal. Ed."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ymgme.2012.08.008","article-title":"Experiences of parents and patients with the timing of Mucopolysaccharidosis type 1 (MPS 1) diagnoses and its relevance to the ethical debate on newborn screening","volume":"107","author":"Ru de","year":"2012","journal-title":"Mol. Gen. Metabol."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0170","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10897-010-9306-0","article-title":"Patient and family experiences and opinions on adding 22q11 deletion syndrome to the newborn screen","volume":"19","author":"Bales","year":"2010","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0738-3991(98)00086-X","article-title":"Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals","volume":"35","author":"Evers-Kiebooms","year":"1998","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0738-3991(97)00069-4","article-title":"Genetic education and counseling","volume":"32","author":"Visser","year":"1997","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0185","series-title":"Analysis in Qualitative Research","isbn-type":"print","author":"Boeije","year":"2009","ISBN":"https:\/\/id.crossref.org\/isbn\/9781847870070"},{"key":"10.1016\/j.ymgme.2013.03.008_bb0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0195","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1007\/s10545-010-9106-6","article-title":"Expanded newborn screening: reducing harm, assessing benefit","volume":"33","author":"Wilcken","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000111635","article-title":"Parental opinions about the expansion of the neonatal screening programme","volume":"11","author":"Detmar","year":"2008","journal-title":"Community Genet."},{"key":"10.1016\/j.ymgme.2013.03.008_bb0205","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1542\/peds.2009-0269","article-title":"Neonatal screening for treatable and untreatable disorders: prospective parents' opinions","volume":"125","author":"Plass","year":"2010","journal-title":"Pediatrics"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T01:32:21Z","timestamp":1644629541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1096719213000978"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabry patients' experiences with the timing of diagnosis relevant for the discussion on newborn screening","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}